Oncologic applications on pet in oncology: the US perspective

FDG PET imaging is rapidly increasing in its utilization in the United States. The reasons for the recent increase in utilization relate to several factors: the instrumentation is now becoming more widely available; the radiopharmaceutical has now received approval by the FDA; and the HCFA and other third party payers are routinely paying for specific indications. As indications for PET imaging increase, the utilization will increase